COVID‐19: a pandemic experience that illuminates potential reforms to health research

Hannah N Kozlowski; Michael E Farkouh; Meredith S Irwin; Laszlo G Radvanyi; Aaron D Schimmer; Uri Tabori; Norman D Rosenblum

doi:10.15252/emmm.202013278

EMBO Molecular Medicine (Oct 2020)

COVID‐19: a pandemic experience that illuminates potential reforms to health research

Hannah N Kozlowski,
Michael E Farkouh,
Meredith S Irwin,
Laszlo G Radvanyi,
Aaron D Schimmer,
Uri Tabori,
Norman D Rosenblum

Affiliations

Hannah N Kozlowski: Biomedical Engineering, University of Toronto
Michael E Farkouh: Peter Munk Cardiac Centre, Heart and Stroke Richard Lewar Centre, University of Toronto
Meredith S Irwin: Department of Paediatrics, The Hospital for Sick Children, University of Toronto
Laszlo G Radvanyi: Ontario Institute for Cancer Research
Aaron D Schimmer: Princess Margaret Cancer Centre, University of Toronto
Uri Tabori: Department of Paediatrics, The Hospital for Sick Children, University of Toronto
Norman D Rosenblum: Department of Paediatrics, The Hospital for Sick Children, University of Toronto

DOI: https://doi.org/10.15252/emmm.202013278
Journal volume & issue: Vol. 12, no. 11
pp. 1 – 4

Abstract

Read online

Abstract COVID‐19 has halted research around the globe and forced researchers out of their laboratories. Non‐emergency medical appointments were canceled. Ongoing clinical trials were challenged to create new modes of operation while public pressure mounted to find therapeutic options against COVID‐19. Yet, the inability to conduct research during COVID‐19 was overcome with cooperation, resource sharing, and compassion, which provides important lessons on how to improve health related research as we enter a new normal.

Published in EMBO Molecular Medicine

ISSN: 1757-4676 (Print); 1757-4684 (Online)
Publisher: Springer Nature
Country of publisher: United Kingdom
LCC subjects: Medicine: Medicine (General); Science: Biology (General): Genetics
Website: https://www.embopress.org/journal/17574684

About the journal